Search results
Ralf Stewart
Author
Marc A Vos
Author
Mark G Hazekamp
Job title: Cardiothoracic surgeon/Paediatric Cardiothoracic Surgeon, Professor in Congenital Cardiothoracic Surgery/Paediatric Cardiothoracic Surgery, Chief Congenital Cardiac Surgery Program CAHAL
Author
Rafail Kotronias
Job title: MD
Author
Sylvia Mamby
Author
Peter Fischbach
Job title: Clinical Associate Professor
Author
Alec Vahanian
Author
Pieter C Smits
Author
Xiangbin Pan
Author
Added:
1 month ago
Source:
Radcliffe CVRM
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are known to reduce major atherosclerotic cardiovascular events, but the full extent of their mechanisms is still being explored. The SEMA-VR CardioLink-15 trial investigated whether semaglutide affects the levels of circulating vascular regenerative (VR) cells, which are involved in vessel repair and may modulate atherothrombotic risk.¹…
View more